spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Drug Eluting Stent 

 HSMN NewsFeed - 24 Apr 2024
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 1 May 2023
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 25 Jan 2023
MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Oct 2022
MedAlliance to be Acquired by Cordis
Devices Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 27 Oct 2021
HT Supreme(R) Drug Eluting Stent performs equivalent to best-in-class in the PIONEER III publication
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2020
MicroVention-Terumo Announces New Leadership
Devices Interventional Personnel
 HSMN NewsFeed - 2 May 2019
Concept Medical Inc. Granted 'Breakthrough Device Designation' From FDA for Its MagicTouch Sirolimus Coated Balloon
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 23 May 2018
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 30 Oct 2017
Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1]
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 Aug 2017
VentureMed Group Raises $15 Million Series B Equity Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 25 Jul 2017
Roxwood Medical Announces Agreement with Abbott for Distribution of Products in U.S.
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 16 May 2017
Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience
Devices Interventional Cardiology
 HSMN NewsFeed - 1 May 2017
Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 26 Apr 2017
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Devices Interventional Drug Delivery
 HSMN NewsFeed - 1 Mar 2017
CeloNova Biosciences Receives FDA Approval of COBRA PzF(TM) Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 21 Nov 2016
OrbusNeich Introduces a New Generation COMBO Plus Dual Therapy Stent for Active Healing
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 7 Jun 2016
InspireMD Names Dr. James Barry as President and CEO
Devices Interventional Personnel
 HSMN NewsFeed - 13 May 2016
Boston Scientific Announces Schedule of Presentations at EuroPCR 2016
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Apr 2016
Abbott to Acquire St. Jude Medical
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 16 Mar 2016
Abbott's Absorb(TM), the First Fully Dissolving Heart Stent, Earns Positive Review by FDA Advisory Committee
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 22 Feb 2016
Boston Scientific Receives CE Mark For Eluvia(TM) Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial
Devices Interventional Regulatory Product Launch
 HSMN NewsFeed - 8 Feb 2016
STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication
Devices Interventional Product Launch
 HSMN NewsFeed - 15 Dec 2015
Svelte Medical Systems Announces CE Mark Certification of SLENDER IDS(TM)
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 Oct 2015
Abbott Announces Positive Clinical Results of Absorb(TM), the Naturally Dissolving Heart Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Oct 2015
Boston Scientific Receives FDA Approval For SYNERGY(TM) Bioabsorbable Polymer Drug-Eluting Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 19 May 2015
Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 Apr 2015
InspireMD Announces Completion of Sales Restructuring Program
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 2 Mar 2015
Tryton Medical Announces Publication of Data from Pivotal Trial for Tryton Side Branch Stent in Journal of American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Sep 2014
World’s First Integrated Delivery System Meets All Endpoints in the Direct II Randomized, Controlled Drug-Eluting Coronary Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Sep 2014
Latest Data Shows OrbusNeich's COMBO(TM) Dual Therapy Stent has Excellent Healing Benefits
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Sep 2014
Tryton Medical Completes $20 Million Equity Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 15 Aug 2014
Cook Medical Enrolls First Patient in Zilver(R) PTX(R) Drug Eluting Peripheral Stent Clinical Study in China
Devices Interventional
 HSMN NewsFeed - 16 Jul 2014
First Patient Enrolment in MASCOT Registry Represents Major Milestone for COMBO(TM) Dual Therapy Stent and OrbusNeich's Clinical Programme
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jul 2014
InspireMD Appoints Dr. James Barry as Chief Operating Officer
Devices Interventional Personnel
 HSMN NewsFeed - 15 Jul 2014
CutisPharma Appoints Neal Muni, MD, MSPH as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2014
Cook Medical Makes Zilver(R) PTX(R) Drug-Eluting Stent Available in Canada
Devices Interventional
 HSMN NewsFeed - 23 May 2014
OrbusNeich Releases Long-term Data for World's First and Only Dual Therapy Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2014
Boston Scientific Reports Strong Performance Data For SYNERGY(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2014
InspireMD to Showcase Embolic Systems with MicroNet(TM) Technology and Results from MASTER I Trial at EuroPCR Conference
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2014
STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2014
Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve(R) 100 Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 1 May 2014
Boston Scientific Launches Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System In Japan
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Apr 2014
Abbott's First-of-Its-Kind MitraClip(R) Device Now Approved in Canada
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 Jan 2014
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme(TM) Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Nov 2013
Svelte Medical Systems Announces Enrollment Complete in the DIRECT II Drug-Eluting Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2013
Abbott's First-In-Class MitraClip(R) Device Now Available for U.S. Patients
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 21 Aug 2013
Abbott Completes Acquisition of IDEV Technologies
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 6 Aug 2013
First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich's COMBO Dual Therapy Stent(TM) in Routine Practice
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jul 2013
Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 10 Jul 2013
Abbott Announces Approval of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent System in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 May 2013
OrbusNeich Launches World's First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 24 May 2013
Elixir Medical Corporation Announces Outstanding Two-Year Results from the EXCELLA BD Randomized Clinical Trial for the CE Mark-Approved DESyne(R) BD System with Biodegradable Polymer Coating
Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2013
Svelte Drug-Eluting Stent Utilizing New Class of Bioabsorbable Drug Coating Attains 0% Clinically-Driven Events Through 12-Months in First-In-Man Study
Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2013
InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2013
Boston Scientific Promus PREMIER(TM) and SYNERGY(TM) Drug-Eluting Stent Systems Provide Exceptional Safety and Efficacy Data
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2013
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 8 May 2013
Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne(R) Nx Novolimus Eluting Coronary Stent System in the United States
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 30 Jan 2013
Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jan 2013
OrbusNeich's COMBO Dual Therapy Stent(TM) to Be Featured During AsiaPCR/SingLIVE 2013 Symposium
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Jan 2013
Abbott Initiates Clinical Trial of Absorb(TM) in the United States
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Jan 2013
InspireMD Names Alan Milinazzo President and CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 19 Dec 2012
First U.S. Patient Treated Following FDA Approval of Cook Medical’s First-of-its-Kind Zilver(R) PTX(R) Drug-Eluting Peripheral Stent
Devices Interventional
 HSMN NewsFeed - 30 Nov 2012
First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY(TM) Coronary Stent System Featuring a Bioabsorbable Polymer Coating
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Nov 2012
Tryton Medical Announces Completion of Patient Enrollment in Landmark Pivotal Study of Side Branch Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Oct 2012
Boston Scientific Receives CE Mark Approval for the SYNERGY(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 24 Oct 2012
Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne(R) System
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2012
The Boston Scientific PROMUS Element(TM) Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Oct 2012
OrbusNeich's COMBO Dual Therapy Stent(TM) to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Oct 2012
Cook Medical’s Zilver(R) PTX(R) Trial Shows Sustained Patency after Three Years
Devices Interventional
 HSMN NewsFeed - 25 Sep 2012
Abbott Announces International Launch of the Absorb(TM) Bioresorbable Vascular Scaffold
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Aug 2012
Elixir Medical Receives CE Mark Approval for the DESyne(R) BD Novolimus Eluting Coronary Stent System With Biodegradable Polymer Coating
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Aug 2012
Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 13 Aug 2012
Cook Medical’s Ongoing Zilver(R) PTX(R) Trial Data Show Higher Freedom From Target Lesion Revascularization (TLR) Rates Compared to Angioplasty and Bare Metal Stenting After Three Years
Devices Interventional
 HSMN NewsFeed - 8 Aug 2012
Cardionovum(R) Expects to Launch Next-Generation Product: Drug-Eluting Coronary Stent System, “PROLIMUS Biograde”
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Aug 2012
Abbott's Omnilink Elite(R) Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 4 Jun 2012
Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element(TM) Plus Platinum Chromium Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 25 May 2012
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
Devices Interventional Cardiology Endocrinology
 HSMN NewsFeed - 23 May 2012
Tryton Announces Positive Clinical Data from More Than 900 Patients Treated with Its Bifurcation Stent System at EuroPCR 2012
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2012
Cook Medical Launches First Drug-Eluting Stent in Australia to Treat Peripheral Arterial Disease (PAD)
Devices Interventional Regulatory
 HSMN NewsFeed - 18 May 2012
PROMUS Element(TM) Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study
Devices Interventional Cardiology
 HSMN NewsFeed - 17 May 2012
Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy Stent(TM) Compared to the TAXUS(R) Stent Shown in Two Clinical Trial Subgroup Analyses
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2012
Elixir Medical Announces Excellent Results from DESolve I First-In-Man Study for the Fully Bioresorbable Drug Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2012
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY(TM) Stent Versus PROMUS Element(TM) Platinum Chromium Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2012
Elixir Medical Announces Continued Excellent One Year Safety and Efficacy Data from the EXCELLA BD Randomized Clinical Trial for DESyne BD(TM) Novolimus Eluting Coronary Stent with Biodegradable Polymer
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2012
Abbott's XIENCE PRIME(TM) and XIENCE V(R) Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 May 2012
Svelte Medical Systems Announces Final Patient Treated in the DIRECT Drug-Eluting Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 10 May 2012
Boston Scientific Announces Schedule For EuroPCR 2012
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Apr 2012
Abbott Receives Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 9 Apr 2012
InspireMD Appoints Robert Ratini as Vice President of Sales and Marketing
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 22 Mar 2012
OrbusNeich's Genous(TM) Technology Effectively Promotes Endothelialization and Reduces Thrombogenicity
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Mar 2012
Biosensors Makes Organizational Changes to Senior Management Team to Prepare for Continued Growth
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 7 Mar 2012
Abbott's Absolute Pro(R) Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 1 Mar 2012
Cook Medical Receives Japanese Approval to Market Its Zilver(R) PTX(R) Drug-Eluting Stent
Devices Interventional Regulatory
 HSMN NewsFeed - 1 Mar 2012
Boston Scientific Announces Launch of PROMUS Element(TM) Platinum Chromium Stent System in Japan
Devices Regulatory Interventional Cardiology
 HSMN NewsFeed - 23 Feb 2012
Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 22 Feb 2012
Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 1 Feb 2012
Boston Scientific Announces First Implant and Market Launch of PROMUS Element(TM) Plus Stent System in Europe
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Jan 2012
Boston Scientific Announces Favorable Ruling in Patent Infringement Case
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 5 Jan 2012
OrbusNeich's Genous(TM) Stent Achieves Good, Comparable Clinical Outcomes in Patients Discontinuing Dual Antiplatelet Therapy at 30 Days and at Six Months
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Dec 2011
Tryton Announces DRG Reimbursement Code for Side Branch Stent in Germany
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 15 Dec 2011
Journal of Endovascular Therapy Publishes Two-Year Data On SUPERA(R) Stent Used in the Superficial Femoral Artery
Devices Interventional
 HSMN NewsFeed - 8 Dec 2011
Abbott Initiates Clinical Trial to Evaluate the Absorb(TM) Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Dec 2011
Data Published in EuroIntervention Indicate that OrbusNeich's Genous(TM) Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Nov 2011
Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 17 Oct 2011
Boston Scientific Launches Promus Element™ Stent System In China
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jul 2011
OrbusNeich's Genous Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Jun 2011
Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent(R) Drug-Eluting Coronary Stent Based on Early Clinical Data
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jun 2011
SurModics Comments on Johnson & Johnson Announcement
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jun 2011
Johnson & Johnson Announces Special Charge Related to Restructuring Plans for Cordis Corporation Subsidiary
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jun 2011
Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Jun 2011
Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 25 May 2011
Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS(R) 2.25 mm Everolimus-Eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2011
Elixir Medical Receives CE Mark for DESyne(TM) Novolimus Eluting Coronary Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 May 2011
Industry’s First Hybrid Drug-Eluting Stent from BIOTRONIK Demonstrates Safety and Efficacy in First-in-Man Clinical Experience
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2011
Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Apr 2011
Boston Scientific Announces FDA Approval and U.S. Launch of ION Platinum Chromium Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 4 Apr 2011
Boston Scientific's Promus Element Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Mar 2011
Medtronic to Unveil Pivotal U.S. Data on Resolute(R) Drug-Eluting Stent at ACC.11
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Feb 2011
REVA Expands Management Team With Key Executive Hire
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 17 Feb 2011
Boston Scientific Launches PROMUS(R) Element and TAXUS(R) Element Stent Systems in India
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Jan 2011
Tryton Announces Enrollment of First U.S. Patient in Pivotal Study of Side Branch Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jan 2011
Cook Medical’s Ongoing Drug-Eluting Peripheral Stent Trial Shows Consistent Outcomes Over 24 Months Compared to One-Year Data
Devices Interventional
 HSMN NewsFeed - 10 Jan 2011
Safety and Efficacy of OrbusNeich's Genous Stent Demonstrated in High-Risk Patients with Known Contraindications for Dual Antiplatelet Therapy
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Jan 2011
Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Dec 2010
Tryton Announces Enrollment of First Patient in U.S. Pivotal Study of Side Branch Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Dec 2010
Tryton Announces Investigational Device Exemption Conditional Approval from FDA to Conduct U.S. Pivotal Study of Side Branch Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 16 Nov 2010
Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 29 Oct 2010
Tryton Presents Positive Six-Month Results for Side Branch Stent System at European Bifurcation Club Meeting
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2010
Patient Enrollment Completed in First Randomized Clinical Study of OrbusNeich's Combo Bio-engineered Sirolimus Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2010
Abbott's XIENCE V(R) Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2010
Abbott's XIENCE V(R) Shows Outstanding Two-Year Clinical Results Versus TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Boston Scientific's TAXUS(R) Element Stent Demonstrates Strong Outcomes in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Long-Term Data Show Advantages for TAXUS(R) Liberte(R) Stent in Small Vessels and Long Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2010
PROMUS(R) Element Stent Approved for Use in Diabetic and Heart Attack Patients in CE Mark Countries
Devices Regulatory Interventional Cardiology
 HSMN NewsFeed - 17 Sep 2010
Elixir Medical Corporation Initiates Enrollment in the EXCELLA BD Randomized Clinical Trial of the Elixir Novolimus Eluting Coronary Stent System with Bioabsorbable Polymer
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Sep 2010
Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK
Devices Regulatory Interventional Cardiology
 HSMN NewsFeed - 2 Sep 2010
Long Term Data Presented at ESC 2010 Further Support the Benefit of The CYPHER(R) Sirolimus Drug-Eluting Stent Compared to The ENDEAVOR(R) Zotarolimus-Eluting Stent in Important High-Risk Subgroups
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Aug 2010
CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Aug 2010
First Patient Treated with Drug Eluting Absorbable Metal Scaffold in the BIOTRONIK "BIOSOLVE-I" Clinical Study
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Aug 2010
Boston Scientific Begins Clinical Trial Enrollment for New Coronary Stent with Bioabsorbable Polymer and Everolimus Drug Coating
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Jun 2010
Boston Scientific Announces European Launch and First Implants of Platinum Chromium TAXUS(R) Element Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Jun 2010
Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer
Devices Neurology Personnel
 HSMN NewsFeed - 26 May 2010
Boston Scientific Begins PLATINUM PLUS Trial for PROMUS(R) Element(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 26 May 2010
For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Medtronic's Resolute(R) Drug-Eluting Stent Matches Market-Leading Rival in Large Head-to-Head Study
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
First Coronary Stent on Drug Eluting Balloon Implanted
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
NEVO Sirolimus-eluting Coronary Stent Continues to Demonstrate Excellent Safety and Efficacy Outcomes in New Twelve-Month Data
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2010
Boston Scientific Announces Schedule for EuroPCR 2010
Devices Interventional Cardiology
 HSMN NewsFeed - 12 May 2010
Boston Scientific Announces European Approval of Platinum Chromium TAXUS(R) Element(TM) Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 6 May 2010
The New England Journal of Medicine Publication of SPIRIT IV Trial Results Confirm Superior Safety and Efficacy of Abbott's XIENCE V(R) Drug Eluting Stent Compared to TAXUS
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2010
Boston Scientific Completes Enrollment in PLATINUM Trials for Small Vessels and Long Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2010
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2010
Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the CYPHER(R) Sirolimus Drug-Eluting Stent over the Endeavor(R) Zotarolimus-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2010
PERSEUS Trial Results Demonstrate Positive Safety and Efficacy Outcomes for Boston Scientific's Novel Platinum Chromium TAXUS(R) Element(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Feb 2010
Stentys Drug-Eluting Self-Expanding Coronary Stent Shows 4% Restenosis in Complex Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Feb 2010
OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Jan 2010
Invatec Comments on First Clinical Results of Drug Eluting Balloon Technology for Below the Knee (BtK)
Devices Interventional
 HSMN NewsFeed - 20 Jan 2010
Court Finds J&J Patents Invalid
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 8 Jan 2010
Svelte Medical Systems, Inc. Announces the Initiation of its European Clinical Trial and the expansion of its Executive Management Team
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 8 Jan 2010
Boston Scientific Announces Japanese Approval for PROMUS(R) Everolimus-Eluting Coronary Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 1 Dec 2009
OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Nov 2009
Boston Scientific Announces European Approval and Launch of Platinum Chromium PROMUS(R) Element(TM) Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 25 Sep 2009
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
Elixir Medical Corporation Announces Positive First-In-Man Results for Three Drug Eluting Coronary Stent Systems with Durable and Bioabsorbable Polymers
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Safe in a Broad Population of Patients with Primary PCI for STEMI
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
TAXUS(R) Liberte(R) Stent Continues to Demonstrate Significant Improvements Over TAXUS(R) Express(R) Stent in Small Vessels and Long Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2009
New Zilver PTX Drug-Eluting Stent from Cook Medical Could Greatly Reduce Need for Leg Amputations and Bypass Surgery for European Patients
Devices Interventional
 HSMN NewsFeed - 18 Sep 2009
Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Sep 2009
Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 2 Sep 2009
Two-Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) EXPRESS(R) Stents and Bypass Surgery
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Aug 2009
First Patient Enrolled in CYPRESS, a Dual Antiplatelet Therapy Trial with the CYPHER(R) Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Aug 2009
Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Aug 2009
Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 13 Aug 2009
Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Aug 2009
Breakthrough Drug-Eluting Stent to Treat Peripheral Arterial Disease Now Available in Europe
Devices Interventional
 HSMN NewsFeed - 11 Aug 2009
Zilver PTX Stent from Cook Medical Gains CE Mark
Devices Interventional Regulatory
 HSMN NewsFeed - 27 Jul 2009
Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 16 Jul 2009
FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 30 Jun 2009
Tryton Announces First Patient Enrollment in E-Tryton 150 Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Jun 2009
Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 16 Jun 2009
Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Jun 2009
SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Jun 2009
vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque
Devices Interventional Cardiology
 HSMN NewsFeed - 27 May 2009
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2009
AMG International Announces the European Regulatory Submission of its Next Generation of Coronary Drug Stents 'Itrix' at European PCR Congress in Barcelona, Spain
Device,s Interventional Cardiology
 HSMN NewsFeed - 21 May 2009
Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2009
NEVO Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus Liberte Stent in Pivotal Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2009
SYNTAX Substudy Shows Positive Outcomes for Left Main Patients Treated With TAXUS(R) Express2(R) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2009
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2009
Endeavor Drug-Eluting Stent is First to Receive CE Mark for Treating Acute Coronary Syndrome
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 19 May 2009
Invatec Officially Launches Coronary Drug-Eluting Balloon Platform IN.PACT Falcon at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2009
Boston Scientific Announces Schedule for EuroPCR 2009
Devices Interventional Cardiology
 HSMN NewsFeed - 14 May 2009
Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 11 May 2009
Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Apr 2009
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Apr 2009
New Clinical Data at ACC09 Show the CYPHER Sirolimus-eluting Coronary Stent Outperformed TAXUS LIBERTE and ENDEAVOR Stents in Key Outcome Measures
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Apr 2009
Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
Devices Interventional
 HSMN NewsFeed - 31 Mar 2009
TYRX Announces the Appointment of George D. Landau as Vice President, Business Development
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 30 Mar 2009
Medtronic Receives Regulatory Approval For Endeavor Drug-Eluting Coronary Stent in Japan
Devices Regulatory Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2009
Boston Scientific Announces Schedule For ACC 2009
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2009
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Mar 2009
XTENT Receives CE Mark Approval for CUSTOM NX (R) Drug-Eluting Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 16 Mar 2009
Cordis Corporation Announces Head-to-Head Randomized Clinical Trial Comparing the NEVO Sirolimus-Eluting Coronary Stent to the XIENCE Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Mar 2009
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Mar 2009
Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Mar 2009
CYPHER Sirolimus-eluting Coronary Stent Demonstrates Sustained Benefits Compared to Bare-Metal Stents in Six-Year Randomized Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Mar 2009
Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 Feb 2009
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Feb 2009
Hospitals, Healthcare Providers to Save with New Premier Drug Eluting Coronary Stents Agreements
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 5 Feb 2009
Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Feb 2009
Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Feb 2009
Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Jan 2009
Angiotech's corporate partner, Boston Scientific, announces Japanese approval for TAXUS(R) Liberté(R) drug-eluting stent system
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 28 Jan 2009
Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 26 Jan 2009
Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jan 2009
Boston Scientific Announces Court Decision
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 15 Jan 2009
Court of Appeals Overturns 2005 Patent Verdict Against Cordis
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 6 Jan 2009
Boston Scientific Acquires Labcoat Limited
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 17 Dec 2008
Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Dec 2008
MGuard(TM) Coronary Stent System Approved in Israel
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 24 Nov 2008
Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President
Devices Cardiology Personnel
 HSMN NewsFeed - 12 Nov 2008
Medtronic Launches Endeavor® Sprint Drug-Eluting Stent System on Rapid Exchange in United States
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Oct 2008
SurModics Licenses Hydrophilic Coating for Elixir's Drug-Eluting and Bare Metal Stent Delivery Systems
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 16 Oct 2008
Elixir Medical Corporation Announced Positive First-In-Man Results from Three Drug Eluting Coronary Stent Systems
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Oct 2008
TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated with Second-Generation TAXUS(R) Liberte(R) Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Oct 2008
Endeavor(R) Vs. Taxus(R): Medtronic's Drug-Eluting Coronary Stent Linked to Fewer Heart Attacks at Two Years Post Implant
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Oct 2008
Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
New Data Shows Abbott's Bioabsorbable Drug Eluting Stent is Absorbed Within Two Years - Leaving Behind Functioning Blood Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2008
Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2008
Medtronic's Third-Generation Endeavor(R) Resolute Drug-Eluting Stent Maintains Strong Efficacy and Safety Profile at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Oct 2008
Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 10 Oct 2008
Elixir Medical Corporation Licenses Myolimus(TM) From Novartis Pharma AG for Site-Specific Drug Delivery Applications
Devices Drug Delivery Licensing Interventional Cardiology
 HSMN NewsFeed - 8 Oct 2008
Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Oct 2008
CeloNova BioSciences to Showcase the CE-Marked CATANIA(TM) Coronary Stent System Featuring NanoThin Polyzene(R)-F at TCT Debut
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Sep 2008
Tryton Medical Announces European Launch of Stent System for Bifurcation Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Sep 2008
Boston Scientific Announces FDA Approval of TAXUS(R) Express2(TM) Atom(TM) Stent System, First Drug-Eluting Stent For Small Vessels
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 15 Sep 2008
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Sep 2008
Tryton Medical Announces Two Key Hires and Relocation to Research Triangle Park, N.C.
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 15 Sep 2008
MIV Therapeutics VESTAsync(TM) Drug-Eluting Stent Trials Progress
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Sep 2008
Cook Medical Completes Enrollment in First International Trial of First-of-Its-Kind Drug-Eluting Peripheral Stent
Devices Interventional
 HSMN NewsFeed - 4 Sep 2008
Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Sep 2008
TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated With Second-Generation TAXUS(R) Liberte(R) Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Sep 2008
SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Sep 2008
Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Aug 2008
The CYPHER(R) Sirolimus-eluting Coronary Stent Outperforms the Taxus(R) Stent in People with Diabetes According to Clinical Data in the Journal of the American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Aug 2008
CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Receives CE Mark Approval for Treatment of Heart Attacks
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 5 Aug 2008
MIV Announces Excellent Safety and Efficacy of VESTAsync(TM) Polymer-Free Drug-Eluting Stent at 12-Month Clinical Follow Up
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Jul 2008
Medtronic Starts U.S. Arm of Global Study Comparing Safety of Endeavor(R) and Cypher(R) Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Jul 2008
Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Jul 2008
FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 20 Jun 2008
XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 11 Jun 2008
Interim Results for the Zilver(R) PTX(TM) Clinical Study from Cook Medical Show Promise for Improving the Treatment of Blockages in the Femoropopliteal Artery
Devices Interventional
 HSMN NewsFeed - 9 Jun 2008
Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Jun 2008
Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 2 Jun 2008
Long-Term Financial Benefits of Drug-Eluting Stents Becoming Evident
Devices Interventional Cardiology
 HSMN NewsFeed - 29 May 2008
Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2008
MIV's Stents Subject of Two Live Cases and Several Presentations at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2008
International Endeavor Registry Reports Safety and Performance of Medtronic Drug-Eluting Stent in Diverse Patient Population
Devices Interventional Cardiology
 HSMN NewsFeed - 14 May 2008
XIENCE(TM) V Drug Eluting Stent from Abbott Reduces Major Adverse Cardiac Events in Small Vessel Patients Out to One Year
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
ENDEAVOR II Four-Year Results Demonstrate Long-Term Safety and Durable Efficacy of Medtronic Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 12 May 2008
Medtronic Announces Start of International Study Comparing Endeavor(R) Resolute Drug-Eluting Stent to Abbott's Xience(R) V
Devices Interventional Cardiology
 HSMN NewsFeed - 6 May 2008
MIV Therapeutics Featured in Cardiovascular Business News
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Apr 2008
Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Apr 2008
Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 17 Apr 2008
Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 4 Apr 2008
Angiotech announces commercial launch of Cook Medical's Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
Devices Interventional
 HSMN NewsFeed - 1 Apr 2008
TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Apr 2008
Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Apr 2008
Elixir Medical Announces Positive Nine-Month Results From the Excella Novolimus-Eluting Coronary Stent System First-In-Man Study
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2008
CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 31 Mar 2008
Tryton Medical, Inc. Closes $14 Million Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 31 Mar 2008
Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2008
Abbott's XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2008
MIV Preliminary Nine-Month Human Data Affirms Excellent Safety and Efficacy of VESTAsync(TM) Polymer-Free Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2008
Three Year Follow-up Data Suggest Better Outcomes Were Maintained with the CYPHER(R) Sirolimus-Eluting Coronary Stent Compared to Brachytherapy in Patients with In-Stent Reblockage
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2008
Large Study Gives Nod to Drug-Eluting Stents in Heart Attack
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2008
Drug-Eluting Stents Outperform Bare Stents in Heart Attack
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
TAXUS(R) Express(TM) Stent Shows Similarly Low Re-intervention Rates in Diabetic Patients Compared to Non-Diabetics in ARRIVE 1 and 2 registries
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2008
Medtronic's New Endeavor(R) Zotarolimus-Eluting Stent Approved for Patients with Coronary Artery Disease in Canada
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 19 Mar 2008
Bifurcated Stent Company Stentys Completes $18 Million 'Series B' Venture Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 11 Mar 2008
Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 4 Mar 2008
MIV Therapeutics Announces Changes to Its Scientific Advisory Board
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 11 Feb 2008
Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Feb 2008
Tryton Medical Receives CE Mark Approval for its Side-Branch Stent
Devices Regulatory Interventional Cardiology
 HSMN NewsFeed - 4 Feb 2008
CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVT's Innovative Stent Coating Technology
Devices Licensing
 HSMN NewsFeed - 2 Feb 2008
Novation First Group Purchasing Organization (GPO) to Have a National Agreement With Medtronic for the Endeavor(R) Zotarolimus-Eluting Coronary Stent
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 1 Feb 2008
Medtronic Receives FDA Approval for Endeavor(R) Zotarolimus-Eluting Coronary Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 1 Feb 2008
Abbott Gains Reimbursement for XIENCE(TM) V Drug Eluting Stent in France
Devices Reimbursement Interventional Cardiology
 HSMN NewsFeed - 31 Jan 2008
Stentys bifurcated stent is successfully implanted for the first time at the Rotterdam ThoraxCenter
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Jan 2008
Boston Scientific Comments on New England Journal of Medicine Article
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jan 2008
Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 7 Jan 2008
MIV Therapeutics Appoints Mark Landy to Additional Post of Chief Executive Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 27 Dec 2007
XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 21 Dec 2007
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 13 Dec 2007
PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Dec 2007
Devax Announces Completion of Enrollment of DIVERGE Trial of Novel Drug- Eluting Stent System for Bifurcation Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Dec 2007
Volcano Announces Agreement to Acquire CardioSpectra
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 29 Nov 2007
Boston Scientific Welcomes FDA Panel Recommendation to Approve PROMUS(TM) / XIENCE(TM) V Everolimus-eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Nov 2007
FDA Advisory Committee Recommends Approval of Abbott's XIENCE(TM) V Drug Eluting Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Nov 2007
Abbott to Present Comprehensive Safety and Efficacy Data on XIENCE(TM) V Drug Eluting Stent to FDA Advisory Committee on Nov. 29
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Nov 2007
5,000 Patients Treated With OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Now Enrolled in Real-Life Use Global Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Nov 2007
New Data Show MIV Therapeutic's Vestasync Drug Eluting Stent Produces Less Fibrinoid and Equivalent Efficacy When Compared to Other Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Nov 2007
Pooled Analysis of Long-Term Data Suggests Cypher(R) Sirolimus-Eluting Coronary Stent Provides Sustained Clinical Benefits in Patients with Coronary Artery Disease Compared to Bare Metal Stents
 HSMN NewsFeed - 5 Nov 2007
Abbott Confirms FDA Advisory Panel to Review XIENCE(TM) V Drug Eluting Stent on November 29
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 5 Nov 2007
At TCT 2007, Cappella Demonstrates Procedural Advantages and Clinical Benefits of Its Technology in Treating Coronary Bifurcations
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2007
Drug Eluting Balloons Show Promise as a Potential Alternative to Drug Eluting Stents Used in the Treatment of Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2007
Safety Profile of Medtronic's Endeavor(R) Drug-Eluting Stent Affirmed in Comprehensive Data Analysis
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2007
Adoption of Drug-Eluting Stents Associated with Lower Health Care Costs and Improved Clinical Outcomes
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Medtronic Receives CE Mark for Endeavor(R) Resolute Drug-Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 22 Oct 2007
Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Endeavor Clinical Program Continues to Provide Positive Safety and Efficacy Data
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
InspireMD's MGuard(TM) Coronary Stent Receives CE Mark
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 22 Oct 2007
Elixir Medical Announces Positive Clinical Results for the Company's First Drug Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
New Long-Term Data Suggest Clinical Differences in Safety and Efficacy between CYPHER(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
MIV Therapeutics Announces Positive Results From First Human Study With Its VESTASYNC Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Oct 2007
New Study Shows Excellent Outcomes for CYPHER(R) Sirolimus-Eluting Coronary Stent in Treatment of Completely Blocked Coronary Arteries
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Oct 2007
Cordis Corporation Announces Clinical Studies and Events at TCT 2007
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Oct 2007
Results of First-In-Man Study With MIVT Low Dose Polymer-Free Drug-Eluting Stent to Be Presented at TCT Conference
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Oct 2007
TriReme Medical Inc. Announces $15.5 Million Series C Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 11 Oct 2007
ARIAD Announces Collaboration with ICON Medical to Develop and Commercialize Novel Deforolimus-Eluting Stents
Devices Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 10 Oct 2007
FDA Advisory Committee Recommends Medtronic's Endeavor(R) Drug-Eluting Stent for Approval
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 5 Oct 2007
Medtronic to Present Findings from the Comprehensive ENDEAVOR Clinical Experience to FDA Advisory Panel
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2007
First-in-Man Milestone Reported for the Stentys Bifurcated Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2007
The CYPHER(R) Sirolimus-Eluting Coronary Stent Outperforms the Taxus Stent in Small Coronary Vessels According to New Clinical Data Analysis Published in the Journal of the American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Sep 2007
Largest Study to Date Finds Drug-Eluting Stents and Bare-Metal Stents Yield Similarly Low Mortality Rates
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Sep 2007
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent on October 10
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 5 Sep 2007
Cardica's C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries
Devices Cardiology Surgery
 HSMN NewsFeed - 5 Sep 2007
TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Sep 2007
Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Sep 2007
Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Sep 2007
Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Sep 2007
Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2007
Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Sep 2007
Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Aug 2007
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent in October
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 14 Aug 2007
InspireMD Received Pre-launch Orders for its MGuard(TM) Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Jul 2007
OrbusNeich Expands Global Sales and Marketing Team
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 19 Jul 2007
Abbott Enrolls First Patient in World's First Clinical Trial Designed to Study Drug Eluting Stent Treatment in Women
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jul 2007
Angiotech's corporate partner, Cook Medical, announces enrollment in pivotal study of paclitaxel-coated stent for use outside the heart
Devices Interventional
 HSMN NewsFeed - 10 Jul 2007
SurModics and Paragon Intellectual Properties to Collaborate on FINALE(TM) Coated Prohealing Stent to Combat Late Stent Thrombosis
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 4 Jun 2007
Positive Results for Second-Generation Taxus(R) Liberte(TM) Coronary Stent System Highlighted in Journal of American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Jun 2007
Abbott Submits XIENCE(TM) V Everolimus Eluting Coronary Stent System Application for U.S. FDA Approval
Devices Interventional Cardiology
 HSMN NewsFeed - 31 May 2007
MIV Therapeutics Announces Start of Clinical Trial Marking First Ever Human Implantation of a Hydroxyapatite Coated Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 24 May 2007
Boston Scientific Receives CE Mark for TAXUS(R) Liberte(TM) Long Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 23 May 2007
Abbott Initiates First Clinical Study of Everolimus Eluting Stent System for Patients with Peripheral Arterial Disease
Devices Interventional
 HSMN NewsFeed - 23 May 2007
Efficacy of OrbusNeich's Genous(TM) Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
Medtronic Announces Positive Nine-Month Results for Endeavor(R) Resolute Next Generation Drug-Eluting Stent at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
Abbott Announces Positive Nine-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
Abbott Announces Continued Positive Results with XIENCE(TM) V Everolimus Eluting Coronary Stent in SPIRIT Clinical Trials
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
CYPHER(R) Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
TAXUS VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
InspireMD Announces Enrollment of 19 Patients in its First in Man Study
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2007
Medtronic Announces Start of 8,800-Patient Clinical Trial Evaluating Drug-Eluting Stent Safety
Devices Interventional Cardiology
 HSMN NewsFeed - 9 May 2007
Study by Cardiologists at Northwestern Memorial Reveals a High Percentage of Heart Patients Receive Off-Label and Untested Drug-Coated Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 7 May 2007
Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
Devices Interventional Cardiology
 HSMN NewsFeed - 1 May 2007
Daniel J. Moore Appointed President and Chief Executive Officer of Cyberonics
Devices Neurology Personnel
 HSMN NewsFeed - 26 Apr 2007
Boston Scientific Announces Completion of Enrollment in Landmark Clinical Trial Comparing Drug-Eluting Stents To Cardiac Surgery
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Apr 2007
COURAGE, SPIRIT Data May Support Role of Advanced Imaging and Diagnosis With IVUS and FFR
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Apr 2007
CINVENTION and Relisys Medical Devices Enroll First Patients in Clinical Trial of the Corel + C Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Apr 2007
MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Apr 2007
Volcano Corporation Reports Use of IVUS Increasing as Physicians Refocus on Stent Technique
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Apr 2007
Boston Scientific Announces Japanese Approval for the TAXUS(R) Express2(TM) Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Mar 2007
Huntington Hospital Cardiologist Available to Comment on Courage Study
Devices Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 27 Mar 2007
CYPHER(R) Sirolimus-eluting Coronary Stent Demonstrates Sustained Benefits Compared to Bare-Metal Stents in Five-Year Randomized Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Mar 2007
SCAI Leaders Say Courage Results Unlikely to Change Use of PCI
Devices Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2007
Two-Year Patient Registry Results Support Safety and Efficacy of CYPHER(R) Sirolimus-Eluting Coronary Stent in 'Real World' Uses
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2007
CYPHER(R) Sirolimus-eluting Coronary Stent Had Similar Results to Bypass Surgery in Long-Term Study of Patients With Multi-Vessel Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2007
Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm Stent's Positive Clinical Profile
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Mar 2007
Boston Scientific Reports Positive Two-Year Data From TAXUS V ISR Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Mar 2007
Boston Scientific Announces Results From Arrive 1 Registry Supporting Positive Performance of TAXUS(R) Stent System in Complex Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2007
Spirit III Clinical Trial Demonstrates Positive Performance for Both TAXUS(R) and PROMUS(TM) Drug-Eluting Stent Systems
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2007
Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Superior to TAXUS(R) Stent in SPIRIT III U.S. Pivotal Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2007
Abbott Announces Positive Six-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Mar 2007
Boston Scientific Announces Industry-Leading Program to Improve Anti-Platelet Compliance for DES Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Mar 2007
Boston Scientific to Provide Information to House Committee on Oversight and Government Reform
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Mar 2007
AGA Medical Appoints Jack Darby as Vice President Worldwide Sales and Marketing
Devices Personnel
 HSMN NewsFeed - 23 Feb 2007
Conor Medsystems to Present COSTAR II Data at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Feb 2007
MIV Therapeutics Completes Acquisition of Biosync Scientific to Expand Operations and Accelerate Commercialization in Fast-Growing Markets
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 12 Feb 2007
Multiple Articles in the New England Journal of Medicine Confirm On-Label, Long-Term Safety and Efficacy of the CYPHER(R) Sirolimus-Eluting Coronary Stent Compared to Bare Metal Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Feb 2007
Boston Scientific Comments on Swedish Registry Results
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Feb 2007
Boston Scientific Welcomes New England Journal of Medicine Articles on Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Feb 2007
Abbott to Initiate First Study to Evaluate XIENCE(TM) V Everolimus Eluting Coronary Stent System in Treatment of Women With Cardiovascular Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Feb 2007
Study Favors Drug-Eluting Stents Over Bare-Metal Stents in Key Patient Outcomes
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Feb 2007
XTENT, Inc. Announces Pricing of Initial Public Offering
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Jan 2007
First International Trial of Drug-Eluting Peripheral Artery Stent Results Encouraging
Devices Interventional
 HSMN NewsFeed - 27 Jan 2007
New Requirements for Drug Eluting Stents Unveiled at CRT 2007
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jan 2007
FDA Approves 18-Month Shelf Life for TAXUS(R) Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 16 Jan 2007
UK Court of Appeal releases decision on Angiotech patent
Devices Biopharmaceuticals Cardiology Litigation
 HSMN NewsFeed - 12 Jan 2007
Study in European Heart Journal Favors TAXUS(R) Stent Over Cypher(R) Stent and Bare-Metal Stents in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Jan 2007
Private-Label Version of Abbott's XIENCE(TM)V Drug-Eluting Coronary Stent System Launches in Europe
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Jan 2007
Boston Scientific Announces First Use of PROMUS(TM) Everolimus-Eluting Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Jan 2007
French Court Rules in Favor of evYsio Medical Devices in Patent Litigation Against Abbott Laboratories
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 20 Dec 2006
CorNova Receives CE Mark for Its Valecor(TM) Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Dec 2006
Implant Sciences' Strategic Partner Receives CE Mark for Its Valecor(TM) Coronary Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 Dec 2006
Kaiser Permanente Reports New Data on Drug-eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Dec 2006
Nano Interface Technology Expands Application of Its Platform Technology to Solve the Problem of the Drug-Coated Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Dec 2006
Medtronic Presents Data on Next Generation Endeavor(R) Drug-Eluting Stent at Special FDA Panel Meeting on DES Safety
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 7 Dec 2006
Real-World Taxus(R) Stent Data Confirm Favorable Outcomes for Patients With Complex Coronary Artery Disease
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 7 Dec 2006
Data Presented To FDA Panel Show TAXUS Drug-Eluting Stents as Safe as Bare-Metal Stents and Far More Effective in Reducing Repeat Procedures
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 7 Dec 2006
Volcano Corporation Announces Collaboration With Stanford University, Cardialysis and Cardiovascular Research Foundation Core Labs to Facilitate In-Depth IVUS Studies of Drug Eluting Stent Safety and Performance
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Dec 2006
American Heart Association Statement on Use of Drug-Eluting Coronary Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Nov 2006
MIV Therapeutics Announces Company's Biocompatible Stents Matches or Outperforms World's Leading Drug-Eluting Stent in Key Categories
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Nov 2006
Cleveland Clinic Analysis Finds Patients With Drug-Eluting Stents Are at Increased Risk for Late Thrombosis
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Nov 2006
Northstar Neuroscience Announces Management Additions; Names Chief Operating Officer and Hires Vice President of Regulatory Affairs and Quality Assurance
Devices Neurology Personnel
 HSMN NewsFeed - 17 Nov 2006
SurModics Provides Additional Information on its License Agreement with Conor Medsystems
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 16 Nov 2006
Johnson & Johnson Announces Definitive Agreement to Acquire Conor Medsystems, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 16 Nov 2006
Medtronic Submits Final PMA Modules to FDA for Approval of the Endeavor Drug-Eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Nov 2006
Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER(R) Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Nov 2006
Study Favors TAXUS(R) Stent Over Cypher(R) Stent and Bare-Metal Stents in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Nov 2006
Volcano Announces Clinical Review of Key Presentations From TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Nov 2006
TAXUS Long-Term Data Excels in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Nov 2006
Clinical Studies to be Presented at American Heart Association Scientific Sessions Demonstrate Growing Body of Efficacy and Safety Data for the CYPHER(R) Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Oct 2006
MIV Therapeutics Announces Timeline for First Human Implantation of HAp NanoFilm Coated Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Oct 2006
TAXUS(R) stents demonstrate excellent efficacy and safety in studies presented at TCT 2006
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2006
Medtronic Announces Positive Results for Endeavor RESOLUTE Drug-Eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2006
Safety and Efficacy Benefits of Next-Generation TAXUS(R) Liberte(TM) Stent Sustained at Twelve Months
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2006
Data in Complex Patients and Lesions from OLYMPIA Registry Support Safety and Efficacy of TAXUS(R) Liberte(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
Abbott Reports Initial Results From World's First Clinical Trial Featuring a Fully Bioabsorbable Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
Cordis to Study Impact of Contributing Factors to Stent Thrombosis in Expansion of 30,000-Stent Patient Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
Data Presented by Independent Physician Panel Confirms Low Rate of Thrombosis with Medtronic Endeavor Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
Independent Meta-Analysis Confirms Safety and Efficacy of TAXUS Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2006
Boston Scientific to Support Landmark STENT Thrombosis Study
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2006
Hydromer, Inc. Announces an Evaluation Phase on its Non-Drug Stent Coating, with Unique Anti-Cell Mitosis Properties
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2006
New Randomized Clinical Trial Results Show the Cypher(R) Sirolimus-Eluting Coronary Stent Outperformed the Taxus Stent in Long Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2006
MIV Therapeutics to Detail Research Results Showing Excellent Performance of Breakthrough Stent Coatings at TCT Conference
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2006
CeloNova Announces Technology that Solves Stent Problems
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2006
TAXUS(R) Performance Superior to Cypher(R) in Diabetic Patients in Head-to-Head Study
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Oct 2006
Volcano Corporation Announces Schedule of Events for TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Oct 2006
Volcano Corporation and MediGuide Ltd. Announce Collaboration for Advanced Imaging and Navigation Technology
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Oct 2006
Medtronic Announces Key Activities at Transcatheter Cardiovascular Therapeutics (TCT) Meeting
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Oct 2006
Medtronic Announces Largest Clinical Study Evaluating Drug-Eluting Stent Safety
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Oct 2006
Boston Scientific to Highlight Broad Range of Clinical Trial Results Reinforcing Safety and Efficacy of TAXUS(R) Coronary Stent Systems at TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Oct 2006
Abbott to Present New Data Across Its Vascular Portfolio at TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Oct 2006
Boston Scientific Becomes only Company with Two Drug-Eluting Stent Platforms With European Approval of Everolimus-Eluting PROMUS(TM) Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 11 Oct 2006
Volcano Announces First Permanent Installations of the Integrated s5i IVUS Imaging System
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Oct 2006
Conor Medsystems Receives Approval for One-Year Shelf Life for CoStar(R) Stent in the European Union
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 5 Oct 2006
CV Therapeutics Receives Notices of Allowance From U.S. Patent and Trademark Office and European Patent Office for Drug-Eluting Stent Technology
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Oct 2006
Medtronic Announces Regulatory Approval for the Endeavor Drug-Eluting Coronary Stent System in Australia
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 4 Oct 2006
Data Suggest Different Outcomes Between The CYPHER(R) Sirolimus-Eluting Coronary Stent and the Taxus Stent In 'Real World' Settings and Small Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Oct 2006
Abbott Begins Early International Launch of XIENCE(TM) V Everolimus Eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Sep 2006
Boston Scientific Welcomes FDA Statement on Drug-Eluting Stents
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 13 Sep 2006
Study in New England Journal of Medicine Suggests Heart Attack Patients Fare Better with CYPHER(R) Sirolimus-eluting Coronary Stents Than Bare Metal Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Sep 2006
Abbott Announces Continued Expansion of Vascular Operations in Ireland to Prepare for Drug Eluting Stent Manufacturing
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Sep 2006
SurModics and X-Cell Medical Collaborate on Drug Eluting Stent Development
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 6 Sep 2006
TAXUS II Clinical Trial Follow-Up Data Demonstrates Excellent Long-Term Outcomes at Four Years
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Sep 2006
Data Suggest the Cypher(R) Sirolimus-Eluting Coronary Stent Provides Sustained Clinical Benefits In Patients With Coronary Artery Disease Compared to Bare Metal Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Jul 2006
SurModics' Hydrophilic Coating Used on CYPHER SELECT(TM) PLUS
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Jun 2006
SurModics and AbbeyMoor Medical to Jointly Develop Drug-Device Convergence Products to Treat Diseases of the Prostate
Devices Urology
 HSMN NewsFeed - 27 Jun 2006
Medtronic Announces Completion of Patient Enrollment in ENDEAVOR IV Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Jun 2006
Cordis Corporation's Third-Generation Coronary Stent Approved for Use in Europe
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 25 May 2006
Sorin Group: Six Month Clinical Results of e-Janus Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2006
Conor Medsystems Announces First Patient Treated with Dual-Drug Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2006
Endeavor Registry Data Confirms High Deliverability Success and Broad, Everyday Use by Physicians
Devices Interventional Cardiology
 HSMN NewsFeed - 17 May 2006
TAXUS(R) coronary stent system cited by EuroIntervention for superiority in diabetic patients
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 17 May 2006
Cordis Corporation Submits Pre-Market Approval Supplement for Direct Stenting
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 17 May 2006
TAXUS(R) Coronary Stent System Cited by EuroIntervention for Superiority in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
Study Suggests Drug-Eluting Stent Type and Vessel Size are Important Predictors of Reblockage in Coronary Artery
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
Xtent CUSTOM I Trial Shows Zero Restenosis, Favorable Late Loss Results at Eight Months
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
TAXUS ATLAS Trial Supports Excellent Deliverability and Proven Outcomes of TAXUS(R) Liberté(TM) stent system
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
Moderate-Release TAXUS(R) Express(TM) Coronary Stent System Demonstrates Sustained Long-Term Outcomes in High-Risk Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
Impressive Clinical Results Show Medtronic ENDEAVOR(TM) Drug-Eluting Coronary Stent Provides Significant Long-Term Safety and Efficacy Benefits
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
TAXUS ATLAS Trial Supports Superior Deliverability and Proven Outcomes of TAXUS(R) Liberte(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
X-Cell Medical Completes Enrollment for Clinical Trial of ETHOS II Estradiol Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
TAXUS(R) Liberte(TM) Stent System Receives European Approval for Three Complex Coronary Procedures
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 May 2006
Patient Registry to Evaluate Long-Term Safety and Efficacy of Cordis Next Generation Drug-Eluting Coronary Stents in Clinical Practice
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2006
SurModics Provides Hydrophilic Coating on Xtent's Drug-Eluting Stent Delivery System
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2006
Abbott Announces First Patients Enrolled in ZOMAXX(TM) EUROPE Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 12 May 2006
Tryton Announces First Clinical Use of its Side-Branch Stent (TM) to Treat Coronary Bifurcation Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 11 May 2006
Cordis Corporation Submits Pre-Market Approval Submission for Reblockage in Coronary Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 11 May 2006
Xtent Appoints Tim Kahlenberg as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 11 May 2006
Conor Medsystems Initiates RAPID Clinical Study for First Pimecrolimus Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 9 May 2006
Boston Scientific to Release Latest Clinical Trial Results on Market-Leading TAXUS(R) Coronary Stent Systems at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 4 May 2006
Boston Scientific Sues Conor Medsystems Ireland Ltd.
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 20 Feb 2006
Sorin Group: Janus Tacrolimus Eluting Carbostent Demonstrates Excellent Safety Profile and Clinical Efficacy in "Real-World" Patients, Particularly in Those With Acute Myocardial Infarction
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 312

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 312 additional stories matching:
Drug Eluting Stent
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.